The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 1, 2005, Pages 151-159

  Cerfolio, Robert James ^a   Bryant, Ayesha S ^b   Ohja, Buddhiwardhan ^b   Bartolucci, Alfred A ^b  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; BIOPSY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; FEMALE; HAZARD ASSESSMENT; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT;

EID: 21744444443     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.11.007     Document Type: Article

References (30)

1. A. Spira, D.S. Ettinger Multidisciplinary management of lung cancer N Engl J Med. 350 2004 379 392
2. R.J. Cerfolio, O. Buddhiwardhan, A.S. Bryant The role of FGD-PET scan in staging patients with non small cell carcinoma Ann Thorac Surg. 76 2003 861 866
3. R.J. Cerfolio, A.S. Bryant, T.S. Winokur Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer Ann Thorac Surg. 78 2004 1903 1909
4. K. Dhital, C.A. Saunders, P.T. Seed, M.J. O'Doherty, J. Dussek (18)F-Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer Eur J Cardiothorac Surg. 18 2000 425 428
5. T.W. McCain, D.P. Dunagan, R. Chin The usefulness of positron emission tomography in evaluating patients for pulmonary malignancies Chest 118 2000 1610 1615
6. N.C. Gupta, G.M. Graeber, H.A. Bishop Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small, intermediate and large lymph node lesions Chest 117 2000 773 778
7. R.M. Pieterman, J.W.G. van Putten, J.J. Meuzelaar Preoperative staging of non-small cell lung cancer with positron emission tomography N Engl J Med. 343 2000 254 261
8. L.G. Strauss Sensitivity and specificity of positron emission tomography for the diagnosis of lymph node metasases Recent Results Cancer Res. 157 2000 12 19
9. J.R. Lee, M.T. Madsen, D. Bushnel A threshold method to improve standardized uptake value reproducibility Nucl Med Commun. 21 2000 685 690
10. H.A. Nabi, J.M. Zubeldia Clinical applications of F18-FDG in oncology J Nucl Med Technol. 30 2002 3 9
11. C.F. Mountain Revisions in the International Systems for Staging Lung Cancer Chest 111 1997 1710 1717
12. D.R. Cox Regression models and life-tables J R Stat Soc [B]. 34 1972 187 220
13. A. Depierre, B. Milleron, D. Moro-Sibilot Preoperative chemotherapy followed by surgery compared with primary surgery in resectable Stage 1 (except T1N0), II and IIIa non-small cell lung cancer J Clin Oncol. 20 1999 247 253
14. R. Rosell, J. Gomez-Codina, C. Camps A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med. 330 1994 153 158
15. J.A. Roth, F. Fossella, R. Komaki A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst. 86 1994 673 680
16. J.A. Roth, E.N. Atkinson, F. Fossella Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
17. R. Rosell, J. Gomez-Codina, C. Camps Preresectional chemotherapy in stage IIIA non-small-cell lung cancer a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
18. The International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med. 350 2004 351 360
19. T.A. D'Amico, T.A. Aloia, M.B. Moore Molecular biologic substaging of stage I lung cancer according to gender and histology Ann Thorac Surg. 69 2000 882 886
20. D.H. Harpole, J.E. Herndon II, W.G. Young Stage I non-small cell lung cancer a multivariate analysis of treatment methods and patterns Cancer 76 1995 787 796
21. D.H. Harpole, J.E. Herndon, W.G. Wolfe A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression Cancer Res. 55 1995 51 56
22. G.M. Strauss, D.J. Kwiatkowski, D.H. Harpole Molecular and pathologic markers in stage I non-small cell carcinoma of the lung J Clin Oncol. 13 1995 1265 1279
23. D.J. Kwiatkowski, D.H. Harpole, J. Godleski Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients clinical implications J Clin Oncol. 16 1998 2468 2477
24. M. Younes, R.W. Brown, M. Stephenson Overexpression of Glut-1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival Cancer 80 1997 1046 1051
25. V. Ahuja, R.E. Coleman, J. Herndon, E.F. Patz Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma Cancer 83 1998 918 924
26. J.F. Vansteenkiste, S.G. Stroobants, P.J. Dupont Leuven Lung Cancer Group Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy- glucose-positron emission tomography scan in non-small-cell lung cancer an analysis of 125 cases J Clin Oncol. 10 1999 3201 3206
27. H.J. Jeong, J.J. Min, J.M. Park Determination of the prognostic value of fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer Nucl Med Commun. 23 2002 865 870
28. K. Higashi, Y. Ueda, Y. Arisaka 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J Nucl Med. 43 2002 39 45
29. R. Sasaki, R. Komaki, H. Macapinlac SUV by FDG-PET predicts outcomes of NSCLC Int J Radiat Oncol Biol Phys. 57 suppl 2 2003 S166
30. R.J. Downey, T. Akhurst, M. Gonen Preoperative F-18 fluorodeoxyglucose- positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection J Clin Oncol. 22 2004 3255 3260